Nektar Therapeutics today reported financial results for the fourth quarter ended December 31, 2025. Cash and investments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results